Literature DB >> 8651357

Pyothorax-associated lymphoma. An unusual case with biphenotypic character of T and B cells.

N Mori1, Y Yatabe, M Narita, T Kobayashi, J Asai.   

Abstract

Pyothorax-associated lymphoma is known to develop in patients who received an artificial pneumothorax for pulmonary tuberculosis some 30 to 40 years previously. Such patients exhibit large, immunoblastic lymphoma cells and often have a B-cell phenotype. We present a patient with an artificial pneumothorax and such a late developing lymphoma but with the unique finding of aberrant T- and B-cell phenotypes. Southern blot hybridization using immunoglobulin gene JH and T-cell receptor beta chain receptors revealed germline configurations. Lymphomas developing in immunocompromised patients, such as those with acquired immunodeficiency syndrome, may show such unusual phenotypes. The unusual phenotypes found in this patient provide evidence that his pyothorax-associated lymphoma was related to an immunocompromised state.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8651357     DOI: 10.1097/00000478-199606000-00015

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  6 in total

1.  Pyothorax-associated lymphoma (PAL): report and review of a rare entity.

Authors:  Katrin Welcker; Masaki Nakashima; Klaus-Dieter Diemel; Lutz Welker; Jürgen Galle; Hartmut Merz; Detlev Branscheid
Journal:  Thorac Surg Sci       Date:  2004-10-01

2.  Expression profile of human herpesvirus 8 (HHV-8) in pyothorax associated lymphoma and in effusion lymphoma.

Authors:  M O'Donovan; I Silva; V Uhlmann; N Bermingham; K Luttich; C Martin; O Sheils; A Killalea; C Kenny; S Pileri; J J O'Leary
Journal:  Mol Pathol       Date:  2001-04

Review 3.  Primary mediastinal (thymic) large B cell lymphoma with aberrant expression of CD3: a case report with review of the literature.

Authors:  Endi Wang; Maggie Stoecker
Journal:  Int J Hematol       Date:  2010-02-04       Impact factor: 2.490

4.  EBV-Positive B-Cell Proliferations of Varied Malignant Potential: 2015 SH/EAHP Workshop Report-Part 1.

Authors:  Yasodha Natkunam; John R Goodlad; Amy Chadburn; Daphne de Jong; Dita Gratzinger; John K C Chan; Jonathan Said; Elaine S Jaffe
Journal:  Am J Clin Pathol       Date:  2017-02-01       Impact factor: 2.493

5.  Clinical and prognostic significance of aberrant T-cell marker expression in 225 cases of de novo diffuse large B-cell lymphoma and 276 cases of other B-cell lymphomas.

Authors:  Naoko Tsuyama; Daisuke Ennishi; Masahiro Yokoyama; Satoko Baba; Reimi Asaka; Yuko Mishima; Yasuhito Terui; Kiyohiko Hatake; Kengo Takeuchi
Journal:  Oncotarget       Date:  2017-05-16

6.  A Unique "Composite" PTLD with Diffuse Large B-Cell and T/Anaplastic Large Cell Lymphoma Components Occurring 17 Years after Transplant.

Authors:  Kristin La Fortune; Dahua Zhang; Gordana Raca; Erik A Ranheim
Journal:  Case Rep Hematol       Date:  2013-05-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.